Atara Biotherapeutics, Inc.
0 sources
Atara Biotherapeutics, Inc. is a Delaware corporation. [1]
Financials
0001193125-26-108361Key Facts
- Atara Biotherapeutics, Inc.'s field of work was post-transplant lymphoproliferative disorder[3].
- Atara Biotherapeutics, Inc.'s field of work was immunotherapy[4].
- Atara Biotherapeutics, Inc.'s field of work was T-lymphocytes[5].
- Atara Biotherapeutics, Inc.'s field of work was Epstein–Barr virus[6].
- Atara Biotherapeutics, Inc. is in the country of United States[7].
- Atara Biotherapeutics, Inc. is in the country of US[8].
- Atara Biotherapeutics, Inc.'s instance of is recorded as business[9].
- Atara Biotherapeutics, Inc.'s instance of is recorded as enterprise[10].
- Atara Biotherapeutics, Inc.'s instance of is recorded as public company[11].
- Atara Biotherapeutics, Inc.'s headquarters location is recorded as South San Francisco[12].
- Atara Biotherapeutics, Inc. is part of NASDAQ Biotechnology Index[13].
- Atara Biotherapeutics, Inc. is part of Russell 2000[14].
- Atara Biotherapeutics, Inc.'s stock exchange is recorded as Nasdaq[15].
- Atara Biotherapeutics, Inc.'s industry is recorded as biotechnology[16].
- Atara Biotherapeutics, Inc.'s industry is recorded as oncology[17].
- Atara Biotherapeutics, Inc.'s industry is recorded as multiple sclerosis[18].
- Atara Biotherapeutics, Inc.'s industry is recorded as autoimmune disease[19].
- Atara Biotherapeutics, Inc.'s industry is recorded as Cellular therapy and transplantation[20].
- 2012 marks the founding of Atara Biotherapeutics, Inc.[21].
- Atara Biotherapeutics, Inc.'s official website is recorded as http://www.atarabio.com/[22].
- Atara Biotherapeutics, Inc.'s legal form is recorded as Delaware corporation[23].
- Atara Biotherapeutics, Inc.'s legal form is recorded as XTIQ[24].
Body
Founding
2012 marks the founding of Atara Biotherapeutics, Inc.[21].
Identity
Part of include NASDAQ Biotechnology Index[13], a stock market index[25], in United States[26] and Russell 2000[14], a stock market index[27], in United States[28].
Operations
Atara Biotherapeutics, Inc.'s headquarters location is recorded as South San Francisco[12].
Industry
Industries include biotechnology[16], oncology[17], multiple sclerosis[18], autoimmune disease[19], and Cellular therapy and transplantation[20]. Fields of work include post-transplant lymphoproliferative disorder[3], a class of disease[29]; immunotherapy[4], a type of medical treatment[30]; T-lymphocytes[5], a cell type[31]; and Epstein–Barr virus[6], a taxon[32].
Ownership
Atara Biotherapeutics, Inc.'s stock exchange is recorded as Nasdaq[15].
Why It Matters
Atara Biotherapeutics, Inc. is known by 4 alternative names across languages and contexts.[2]